Stockscreener 앱 받기
9.74
0.52%
0.05
시간 외 거래:
9.74
Neumora Therapeutics Inc (NMRA) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
| 기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-30 |
| 기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
47.31%
60.07
|
114.00 | 56.86 | - | - |
| Operating Income/Loss |
47.31%
-60.07
|
-114.00 | -56.86 | - | - |
| Nonoperating Income/Loss |
14.63%
6.353
|
5.542 | 3.837 | - | - |
| Income/Loss From Continuing Operations Before Tax |
50.47%
-53.72
|
-108.46 | -53.03 | -38.54 | -35.62 |
| Income/Loss From Continuing Operations After Tax |
50.59%
-53.72
|
-108.73 | -53.03 | -38.54 | -35.62 |
|
Net Income/Loss
|
50.59%
-53.72
|
-108.73 | -53.03 | -38.54 | -35.62 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
433.72%
157.94
|
29.59 | 46.69 | - | - |
| Diluted Average Shares |
433.72%
157.94
|
29.59 | 46.69 | - | - |
| Basic Earnings Per Share |
750.00%
-0.34
|
-0.04 | -1.14 | - | - |
| Diluted Earnings Per Share |
750.00%
-0.34
|
-0.04 | -1.14 | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.89%
2.08%
자본화:
|
볼륨(24시간):